All events occur at the Gaylord National Resort & Convention Center, unless otherwise noted. Schedule is subject to change.

B4: Medical Optimization of the Vasculopath
Room: Maryland A

At the end of this session, participants should be able to:

1. Discuss the importance of, appropriate indications for, and appropriate management of platelet inhibition in the vasculopath.
2. Discuss the importance of, appropriate indications for, and benefits of aggressive lipid therapy in the vasculopath.
3. Discuss the importance of, appropriate indications for, and outcomes of appropriate beta blockade in the vasculopath.
4. Discuss the risks and benefits of, and indications for cilostazol therapy in the vasculopath.
5. Discuss the benefits of action and benefits of exercise therapy relative to other intervention in the vasculopath.

Moderators: Kellie Brown MD, Medical College of Wisconsin, Milwaukee, WI
Anthony J. Comerota MD, Jobst Vascular Center, Toledo, OH

 

6:30 am
The Importance of Platelet Inhibition in Patients with Vascular Disease
Peter K. Henke MD, University of Michigan, Ann Arbor, MI

 

6:40 am
Statins: Are we Doing Enough by Treating Every Patient and Following LDL?
Emile R. Mohler, III MD, Penn Heart and Vascular Center, Philadelphia, PA

 

6:50 am
Beta Blockers: The Key to Reducing Procedure-Related Ischemic Events
Christopher J. Abularrage MD, The Johns Hopkins Hospital, Baltimore, MD

 

7:00 am
Cilostazol Reduces Recurrent Stenosis and Stroke in Addition to Improving Claudication Distance
Anthony J. Comerota MD, Jobst Vascular Center, Toledo, OH

 

7:10 am
Structured Exercise Improves Walking Distance Better than Angioplasty and Stenting in Patients with Aortoiliac Occlusive Disease: CLEVER
Emile R. Mohler, III MD, Penn Heart and Vascular Center, Philadelphia, PA

 

7:20 am
Panel Discussion

B5: Endovascular Treatment of the Lower Extremity
Room: Maryland C

 

At the end of this session, participants should be able to:

1. Identify role of atherecotmy in lower extremity arterial disease.
2. Describe advanced techniques for crossing and distal access for lower extremity disease.
3. Identify changes in stent design and FDA approval process.
4. Explain differences in outcomes of tibial interventions versus SFA interventions.

Moderators: Sean P. Lyden MD, The Cleveland Clinic Foundation, Cleveland, OH
Brian G. DeRubertis MD, UCLA School of Medicine, Los Angeles, CA

 

6:30 am
Defining Atherectomy's Role in Todays Practice: Primary Modality or Niche Device?
Rabih A. Chaer MD, University of Pittsburgh, Pittsburgh, PA

 

6:42 am
Stenting The SFA:  Does Stent Design Or FDA-Approval Matter?
Darren B. Schneider MD, Weill Cornell Medical College, New York, NY

 

6:54 am
Look Into The Future:  Current Status Of Drug Coated Balloons, Drug Eluting Stents And Bioabsorbable Stents?
Christopher D. Owens, MD, MSc, University of California San Francisco Medical Center, San Francisco, CA

 

7:06 am
CTO Crossing:  Reentry Tips, Techniques and Devices
Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI

 

7:18 am
Infrageniculate Interventions: Treatment Modalities and Outcomes
Andres Schanzer MD, University of Massachusetts Medical School, Worcester, MA

 

7:30 am
Techniques for Pedal Access and Pedal Loop Interventions
Neal S. Cayne MD, New York University Medical Center, New York, NY

 

7:42 am
Panel Discussion

B6: Genetics and Vascular Disease
Room: Maryland D

At the end of this session, participants should be able to:

1. Describe the process of genetic testing and advances that have been made in this field.
2. Explain the influence of genetics on the development of vascular disease.
3. Discuss how genetic testing may influence the medical and surgical treatment of patients with arterial disease.

Moderators: Matthew J. Eagleton MD, The Cleveland Clinic, Cleveland, OH
Dianna M. Milewicz MD PhD, The University of Texas Health Science Center at Houston, Houston, TX

 

6:30 am
Progress in Genetic Testing
Peter H. Byers MD, University of Washington, Seattle, WA

 

6:40 am
Disease Pattern Predictions Based on Family History
Chase R. Brown, The Cleveland Clinic Foundation, Cleveland, OH

 

6:50 am
Genetic Influence on Aortic Aneurysm Development
Helena Kuivaniemi MD, Geisinger Health System, Danville, PA

 

7:00 am
Genetics and Venous Disease Development
David L. Gillespie MD, University of Rochester, Rochester, NY

 

7:10 am
Genetic Implications in Aortic Disease Management
Dianna M. Milewicz MD PhD, The University of Texas Health Science Center at Houston, Houston, TX

 

7:20 am
Genetic Testing - Does it Alter Surgical Approaches to Aortic Disease?
James H. Black MD, Johns Hopkins Medical Center, Baltimore, MD

 

7:30 am
Do Genetics Affect Outcomes of Surgery for PAD?
Michael S. Conte MD, University of California, San Francisco, San Francisco, CA

 

7:40 am
Point of Care Genetic Testing - Coming to Your OR?
Richard B. Horenstein MD, University of Maryland School of Medicine, Baltimore, MD

 

7:50 am
Panel Discussion

6:30 am
Welcome
Indravadan Kapadia MS PA-C, Saint Michael's Medical Center, Newark, NJ

 

6:40 am
Proving Your Value as a Vascular Surgery PA
Sophia Serrano MS PA-C, University of Texas Southwestern, Dallas, TX

 

6:55 am
Optimization of a Physician-PA Vascular Surgery Health Care Team
Sophia Serrano MS PA-C, University of Texas Southwestern, Dallas, TX

 

7:10 am
Cracking the Code for Success in Vascular Surgery
James Becker PA-C, NGPG Surgery Associates, Gainesville, GA
Indravadan Kapadia MS PA-C, Saint Michael's Medical Center, Newark, NJ

 

7:25 am
Panel Discussion

*This program is not eligible for CME credit.

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
2. Identify new technology for diagnosis and treatment of vascular disease.

Moderators: Peter Gloviczki, MD, Mayo Clinic, Rochester, MN
Roy K. Greenberg, MD, The Cleveland Clinic Foundation, Cleveland, OH

 

8:00 am
SS17. Supraclavicular Decompression for Neurogenic Thoracic Outlet Syndrome (NTOS) in Pediatric and Adult Populations: Differential Patient Characteristics and Clinical Outcomes
Francis J. Caputo, Anna M. Wittenberg, Chandu Vemuri, Valerie B. Emery, Robert W. Thompson
Surgery, Washington University in St. Louis, St. Louis, MO.

 

8:14 am
SS18. Monitoring of Fetal Radiation Exposure During Pregnancy
Venita Chandra¹, Chelsea A. Dorsey¹, Amy B. Reed², Palma Shaw³, Wei Zhou^1
1Vascular Surgery, Stanford Hospital and Clinics, Stanford, CA; ²Penn State Hershey Medical Center, Hershey, PA; ³Brigham and Women's Hospital, Boston, MA.

 

8:28 am
Video Presentation
VS5. Challenging Inferior Vena Cava Filter Retrieval
Paul J. Foley, Grace J. Wang, Benjamin J. Herdrich, Erin H. Murphy, Bruce P. Landau, Edward Y. Woo, Ronald M. Fairman, Benjamin M. Jackson
Surgery, University of Pennsylvania, Philadelphia, PA.

 

8:38 am
Basic Research State of the Art Presentation
SS19. An Update on Critical Research Issues in Venous Disease
Peter K. Henke MD
University of Michigan, Ann Arbor, MI

 

8:52 am
SS20. Focusing Quality Improvement in PAD: Regions With the Highest Amputation Rates Receive the Least Vascular Care
Philip P. Goodney¹, Lori L. Travis³, Benjamin S. Brooke¹, Kerianne Holman⁴, Peter K. Henke⁴, David A. Goodman², Jack L. Cronenwett¹, John D. Birkmeyer⁴, Elliott S. Fisher^2
1Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; ²The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH; ³Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME; ⁴University of Michigan, Ann Arbor, MI.

 

9:06 am
SS21. Mechanochemical Ablation (MOCA) of the Great Saphenous Vein: 2-year Results and Recommendations from the Initial Human Trial
Steve Elias
Columbia University and Medical Center, Englewood, NJ.

Attendees will be able to explore the advantages and disadvantages of simulation for open and endovascular procedures; identify areas to focus on for improving skills; and have the opportunity to experience simulation training on less commonly performed procedures. Please note pre-registration is required for this event.

*This program is not eligible for CME credit. 

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
2. Identify new technology for diagnosis and treatment of vascular disease.

Moderators: Julie Ann Freischlag, MD, Johns Hopkins University School of Medicine, Baltimore MD
Linda M. Harris, MD, University of Buffalo Surgeons, Buffalo, NY

10:30 am
SS22. See One, Sim One, Do One, Teach One: Results of a Prospective Randomized Trial of Endovascular Skills Training for Surgical Residents
Jason T. Lee, Amy Peruzzaro, Thomas Krummel, Ronald L. Dalman
Division of Vascular Surgery, Stanford University Medical Center, Stanford, CA.

 

10:44 am
SS23. Outcomes Comparison of HeRO and Lower-extremity Arteriovenous Graft in Patients with Longstanding Renal Failure
Samuel N. Steerman, Jason Wagner, Jonathan A. Higgins, Claudia Kim, Aleem Mirza, James Pavela, Jean M. Panneton, Marc Glickman
Eastern Virginia Medical School, Norfolk, VA.

 

10:58 am
Video Presentation
VS6. Percutaneous Thrombectomy of a Dialysis Graft in the Office Setting
Krishna Jain¹, John Munn², Mark Rummel², Dan Johnston², Chris Longton^2
1Advanced Vascular Surgery, Kalamazoo, MI; ²Advanced Vascular Surgery, Kalamazoo, MI.

 

11:08 am
SS24. Hemodialysis Access and Age-related Postoperative Outcomes: Which Fistula First?
Steven Abramowitz, Angela A. Kokkosis, Jonathan Schwitzer, Harry Schanzer, Victoria Teodorescu
Mount Sinai Medical Center, New York, NY.

1:00 pm - 5:00 pm           Postgraduate Simulation Training Sessions*
                                        Room: Exhibit Halls A-C

Attendees will be able to explore the advantages and disadvantages of simulation for open and endovascular procedures; identify areas to focus on for improving skills; and have the opportunity to experience simulation training on less commonly performed procedures. Please note pre-registration is required for this event.

*This program is not eligible for CME credit.

At the end of this session, participants should be able to:

1. Describe the types of clinical trials relevant to vascular disease.
2. Examine the bias that can affect the interpretation of trial data.
3. Review publications that may influence clinical practice.

Moderators: Gregory L. Moneta MD, Oregon Health and Sciences University, Portland, OR
Vikram S. Kashyap MD, University Hospitals Case Medical Center, Cleveland, OH

 

1:30 pm
Introduction
Gregory L. Moneta MD, Oregon Health and Sciences University, Portland, OR

 

1:35 pm
1. Low Prevalence of Abdominal Aortic Aneurysm Among 65-Year-Old Swedish Men Indicates a Change in the Epidemiology of the Disease
Circulation 2011;124:1118-1123
Presentation and Discussion by: Jonathan L. Eliason MD, University of Michigan, Ann Arbor, MI

 

1:40 pm
2. Predictors of Abdominal Aortic Aneurysm Sac Enlargement After Endovascular Repair
Circulation 2011;123:2848-2855
Presentation and Discussion by: Ahmed M. Abou-Zamzam MD, Loma Linda University Medical Center, Loma Linda, CA

 

1:45 pm
3. Effect of Hypoxia-Inducible Factor-1 Gene Therapy on Walking Performance in Patients With Intermittent Claudication
Circulation 2011; 124:1765-1773
Presentation and Discussion by: Omaida C. Velazquez, MD University of Miami, Miami, FL

 

1:50 pm
Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease
Circulation 2012;125:00-00
Presentation and Discussion by: David Rigberg, MD, UCLA Medical Center, Los Angeles, CA

 

1:55 pm
5. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
Lancet 2012; 379: 31–38
Presentation and Discussion by: Cynthia K. Shortell MD, Duke University Medical Center, Durham, NC

 

2:00 pm
Discussion

 

2:10 pm
Non-selected Papers
Vikram S. Kashyap MD, University Hospitals Case Medical Center, Cleveland, OH

 

2:13 pm
6. Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension : Durability of Blood Pressure Reduction Out to 24 Months
Hypertension 2011; 57:911-917
Presentation and Discussion by: Vikram S. Kashyap MD, University Hospitals Case Medical Center, Cleveland, OH

 

2:18 pm
7. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
Lancet 2011; 378: 1547–59
Presentation and Discussion by: Russell H. Samson MD, Mote Vascular Foundation and Sarasota Vascular Specialists, Sarasota, FL

 

2:23 pm
8. Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
JAMA 2011;306(20):2221-2228
Presentation and Discussion by: Raul J. Guzman MD, Vanderbilt University Medical Center, Nashville, TN

 

2:28 pm
9. Health-Related Quality of Life After Carotid Stenting Versus Carotid Endarterectomy
J Am Coll Cardiol 2011; 58:1557–65
Presentation and Discussion by: Jerry Goldstone MD, University Hospitals Case Medical Center, Cleveland, OH

 

2:31 pm
10. Myocardial Infarction After Carotid Stenting and Endarterectomy
Circulation 2011;123:2571-2578
Presentation and Discussion by: Jerry Goldstone MD, University Hospitals Case Medical Center, Cleveland, OH

 

2:34 pm
11. Age and Outcomes After Carotid Stenting and Endarterectomy
Stroke 2011;42:3484-3490
Presentation and Discussion by: Jerry Goldstone MD, University Hospitals Case Medical Center, Cleveland, OH

 

2:37 pm
Discussion

CONCURRENT BREAKOUT SESSIONS

At the end of this session, participants should be able to: 

1. Identify the limitations of the three possible approaches to endografting patients with juxtarenal abdominal aortic aneurysms.
2. Discuss patient selection and the pre-operative planning for the three possible approaches to endografting patients with juxtarenal abdominal aortic aneurysms.
3. Identify the potential complications of endografting juxtarenal abdominal aortic aneurysms and how to best resolve them.
4. Interpret pre and post endografting CT imaging of patients with juxtarenal abdominal aortic aneurysms.
5. Discuss current best medical management of patients with carotid bifurcation disease and expected outcomes in patients treated exclusively by medical management.
6. Identify patients suitable for carotid stenting, the role for concomitant medical therapy, and their expected outcomes.
7. Discuss the role for carotid endarterectomy in patients with carotid stenosis, as well as potential and presently accepted complication rates.
8. Report of the findings of the major carotid stenting trials and how the outcomes of carotid stenting compared to those of carotid endarterectomy.

Moderators: Kim J. Hodgson MD, Southern Illinois University, Springfield, IL
Carlo Setacci MD, University of Siena, Siena, Italy

 

Debate I

The Best Management Approach for Juxtarenal Abdominal Aortic Aneurysms (JAAs) In the Foreseeable Future

 

3:30 pm
Physician Modified (Fenestrated) Endovascular Grafts (PMEGs) Should Be the Standard Approach for Managing Juxtarenal Abdominal Aortic Aneurysms
Benjamin W. Starnes MD, University of Washington, Seattle, WA

 

3: 40 pm
Open Repair Remains the Procedure of Choice for Most Juxtarenal Aneurysms
Jean-Baptiste Ricco MD PhD, University Hospital, Poitiers, France

 

3:50 pm
An Off-The-Shelf Solution Will Soon Be Available (Ventana) and Should Be the Standard Approach for Managing JAAs
Daniel G. Clair MD, The Cleveland Clinic, Cleveland, OH

 

4:00 pm
Discussion

 

Debate II

The Long Awaited CREST Results Have Now Been Published, So Why Is Carotid Artery Stenting (CAS) For Asymptomatic Disease Languishing?

 

4:15 pm
The Preponderance of Trial Data Reinforce the Superiority of Carotid Endarterectomy for Asymptomatic Carotid Disease
Andrea Stella MD, University of Bologna, S Orsola-Malpighi Hospital, Bologna, Italy

 

4:25 pm
CAS Outcomes Are Equivalent, If Not Better Than Those with CEA and Its Use Should Be Liberalized
Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI

 

4:35 pm
Medical Management of Asymptomatic Carotid Bifurcation Disease Should Be the Mainstay of Therapy, With Revascularization Reserved For Patient's With New Symptoms While On Optimal Medical Management
John F. Eidt MD, University of Arkansas for Medical Sciences, Little Rock, AR

4:45 pm
Discussion

C8: Joint Session SVS/SVU: Hemodialysis Access
Room: Maryland A

At the end of this session, participants should be able to:

1. Apply meaningful and effective protocol for AV access mapping.
2. Discuss influence of K/DOQI guidelines on access choices.
3. Identify normal and abnormal findings when evaluating AV access maturation.
4. Apply Duplex criteria appropriately for pre-op and post-op examinations.
5. Describe current practices.
6. Identify future investigational avenues.

Moderators: Alan M. Dietzek MD, Danbury Hospital in Connecticut, Ridgefield, CT
Gail Hadley RN RVT FSVU, Massachusetts General Hospital, Boston, MA

 

3:30 pm
Introduction

 

3:35 pm
Protocol Excellence in Pre-operative Access Mapping
Kelly Byrnes BS RVT, Norton Hospital, Louisville, KY

 

3:45 pm
Case Examples: Duplex Findings that Influence Access Choice
Virginia Makeham RN RVT DMU, Royal Prince Alfred Hospital, Sydney, Australia

 

3:55 pm
How to Decide on the Best Access for a Patient; Is Compliance with K/DOQI Guidelines Always Best?
Eric K. Peden MD, Methodist DeBakey Heart & Vascular Center, Houston, TX

 

4:05 pm
How to Determine When an Access is Ready for Use and is Ongoing Surveillance Worth the Cost?
Clifford M. Sales MD MBA, The Cardiovascular Care Group, Westfield, NJ; Overlook Medical Center, Summit , NJ

 

4:15 pm
Access-related Complications
Larry A. Scher MD, Montefiore Medical Center, Bronx, NY

 

4:25 pm
What’s New in Hemodialysis Access and What’s on the Horizon
George H. Meier MD, University of Cincinnati School of Medicine, Cincinnati, OH

 

4:35 pm
Panel Discussion

 

C9: Poster Session
Room: Exhibit Halls A-C

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
2. Identify new technology for diagnosis and treatment of vascular disease.

Moderator: Peter F. Lawrence MD, UCLA Medical Center, Los Angeles, CA

 

3:30 pm
Introduction and Rules

3:40 pm
PS2. Fenestrated/Branched Endovascular Aortic Repair (FEVAR) for Chronic Type B Aortic Dissection with Thoracoabdominal Aneurysms (TAAA)
Atsushi Kitagawa1, Roy K. Greenberg¹, Matthew J. Eagleton¹, Tara M. Mastracci¹, Eric Roselli^2
1The Cleveland Clinic Department of Vascular Surgery, Cleveland, OH; ²The Cleveland Clinic Department of Thoracic Surgery, Cleveland, OH.

 

3:45 pm
PS4. Biomechanical Rupture Risk Assessment of AAA Made Easier for Clinicians
Joy Roy¹, Jesper Swedenborg¹, Natzi Sakalihasan², Alain Nchimi², Dittmar Bockler³, Alexander Hyhlik-Durr³, Christian Gasser^4
1Department of Vascular Surgery, Karolinska Hospital/Institute, Stockholm, Sweden; ²University Hospital of Liege, Liege, Belgium; ³University of Heidelberg, Heidelberg, Germany; ⁴Royal Institute of Technology, Stockholm, Sweden.

 

3:50 pm
PS6. Population-based Study of Age and Gender Effects in Aneurysm Anatomy
Tina M. Morrison¹, Xu Yan¹, Dorothy B. Abel¹, Ron M. Fairman², Marc H. Glickman³, Mark F. Fillinger^4
1Division of Cardiovascular Device - Office of Device Evaluation, Food and Drug Administration, Silver Spring, MD; ²University of Pennsylvania Medical Center, Philadelphia, PA; ³Sentara Norfolk General Hospital, Norfolk, VA; ⁴Dartmouth-Hitchcock Medical Center, Lebanon, NH.

 

3:55 pm
PS8. Role of Intraoperative Aneurysm Sac Embolization During EVAR in the Prevention of Type II Endoleak
Michele Piazza¹, Paola Scrivere¹, Michele Antonello¹, Stefano Bonvini¹, Alberto Dall'Antonia¹, Franco Noventa⁴, Joseph J. Ricotta³, Franco Grego¹, Paolo Frigatti^2
1Vascular and Endovascular Surgery, Padova University, Padova, Italy; ²Vascular and Endovascular Surgery, Udine Clinic, Udine, Italy; ³Vascular and Endovascular Surgery, Emory Clinic, Atlanta, GA; ⁴Clinic of Medicine IV, Padova University, Padova, Italy.

 

4:00 pm
PS10. Perioperative Administration of Alvimopan, a Novel Peripherally Acting Mu-opioid Receptor Antagonist, is Associated with Improved Resource Utilization in Patients Undergoing Open Aortic Surgery
Matthew B. Burruss, Bryan A. Ehlert, Timothy W. Capps, William M. Bogey, Frank M. Parker, Charles S. Powell, Michael C. Stoner
East Carolina University Heart Institute, Brody SOM, Greenville, NC.

 

4:05 pm
PS12. Open Repair of Aortic Coarctation in Adults
Kristofer M. Charlton-Ouw, Maria E. Codreanu, Samuel S. Leake, Harleen K. Sandhu, Daniel Calderon, Ali Azizzadeh, Anthony L. Estrera, Hazim J. Safi
Department of Cardiothoracic and Vascular Surgery, University of Texas at Houston Medical School, Houston, TX.

 

4:10 pm
PS14. EVAR in the Elderly: Trends and Outcomes from the Nationwide Inpatient Sample
Brian D. Park¹, Nchang M. Azefor¹, Chun-Chih Huang¹, Cameron Akbari¹, Frederick P. Beavers¹, David Deaton², Robyn S. Macsata³, Sean O'Donnell¹, Susanna Shin¹, John J. Ricotta^1
1The Washington Hospital Center, Washington, DC; ²Georgetown University Hospital, Washington, DC; ³Veterans Affairs Medical Center, Washington, DC.

 

4:15 pm
PS16. Intra-thoracic Subclavian Artery Aneurysm Repair in the Thoracic Endovascular Era
Michael E. Barfield, Nicholas D. Andersen, Asad A. Shah, Cynthia K. Shortell, Richard L. McCann, G. Chad Hughes
Duke University Medical Center, Durham, NC.

 

4:20 pm
PS18. Endoleaks After Endovascular Repair of Ruptured Abdominal Aortic Aneurysm: Do They Matter?
Brandon T. Garland, Elina Quiroga, Benjamin W. Starnes, Thomas Hatsukami, Nam T. Tran
Division of Vascular Surgery, University of Washington, Seattle, WA.

3:40 pm
PS20. Endovascular Repair Using Standard Suprarenal Fixation Endograft is Feasible and Effective in Abdominal Aortic Aneurysm with Infra-renal Neck Length 5-10 mm
Mauro Gargiulo¹, Enrico Gallitto¹, Claudio Bianchini Massoni¹, Antonio Freyrie¹, Gianluca Faggioli¹, Carla Serra¹, Joseph J. Ricotta², Andrea Stella^1
1Vascular Surgery, University of Bologna, Bologna, Italy; ²Vascular Surgery, Emory University, Atlanta, GA.

 

3:45 pm
PS22. Endovascular Salvage for Complications of Open Aortic Surgery
Erin H. Murphy, Benjamin J. Herdrich, Benjamin M. Jackson, Grace J. Wang, Jeffrey P. Carpenter, Ronald M. Fairman, Edward Y. Woo
Vascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.

 

3:50 pm
PS24. Evaluation of Aortic Arch Motion in Physician-modified Endografts During TEVAR
Frank R. Arko¹, J Michael Dimaio², Jeko Madjarov¹, Tzvi Nussbaum¹, Stephen Llaka¹, Timothy Roush^1
1Vascular Surgery, Sanger Heart and Vascular Institute, Charlotte, NC; ²University of Texas Southwestern Medical Center, Dallas, TX.

 

3:55 pm
PS26. Vascular Surgeons Repair an Increasing Majority of Abdominal Aortic Aneurysms After the Introduction of EVAR
Rob Hurks¹, Rodney P. Bensley¹, Ruby C. Lo¹, Michael D. Howell¹, George S. DaSilva¹, Mark C. Wyers¹, Allen D. Hamdan¹, Frans L. Moll², Marc L. Schermerhorn^1
1Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA; ²University Medical Center Utrecht, Utrecht, The Netherlands.

 

4:00 pm
PS28. Toward Improved Prediction of AAA Rupture Risk: Implementation of Geometric Quantification Measures Rather than Maximum Diameter Alone
Judy Shum¹, Satish Muluk², Adam J. Doyle³, Ankur Chandra³, Mark Eskandari⁴, Ali Azizzadeh⁵, Ender A. Finol^6
1Carnegie Mellon University, Pittsburgh, PA; ²West Penn Allegheny Health System, Pittsburgh, PA; ³University of Rochester Medical Center, Rochester, NY; ⁴Northwestern Memorial Hospital, Chicago, IL; ⁵The University of Texas Health Science Center at Houston, Houston, TX; ⁶Biomedical Engineering, The University of Texas at San Antonio, San Antonio, TX.

 

4:05 pm
PS30. Changing Trend of Mortality Rate from Ruptured and Non-ruptured Abdominal Aortic Aneurysm in Last Three Decades in USA
Marjan U. Mujib, Marc A. Passman, Francisco Alcocer, Thomas C. Matthews, Marc A. Patterson, Bart R. Combs, Bruce G. Lowman, William D. Jordan
Surgery, University of Alabama at Birmingham, Birmingham, AL.

 

4:10 pm
PS32. Utilization of Motor-evoked Potential Monitoring During TEVAR: Can the Incidence of Spinal Cord Injury Be Reduced?
Ali Shahriari, James Williams
The Indiana Heart Hospital, Indianapolis, IN.

 

4:15 pm
PS34. Follow-up After Endovascular Aneurysm Repair: No Imaging up to 5-Years as the Preferred Strategy for Selected Patients
Frederico M. Bastos Gonçalves, Sander ten Raa, Ellen V. Rouwet, Johanna M. Hendriks, Adriaan Moelker, Hence J. M. Verhagen
Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.

 

4:20 pm
PS36. Abdominal Aortic Bifurcation Anatomy and Endograft Limbs’ Size Affect the Use of Adjunctive Iliac Stenting During Endovascular Abdominal Aortic Aneurysm Repair
Claudio Bianchini Massoni¹, Mauro Gargiulo¹, Antonio Freyrie¹, Enrico Gallitto¹, Federica Giovanetti¹, Joseph J. Ricotta², Andrea Stella^1
1Vascular Surgery, University of Bologna, Bologna, Italy; ²Vascular Surgery, Emory University, Atlanta, GA.

3:40 pm
PS38. Increased Rate of Myocardial Infarction with Carotid Endarterectomy Under General Anesthesia: A Population-based Study
Jaime Benarroch-Gampel, Kristin M. Sheffield, Lorraine Choi, Casey A. Boyd, Taylor S. Riall, Lois A. Killewich
Surgery, University of Texas Medical Branch, Galveston, TX.

 

3:45 pm
PS40. Asymptomatic 50-75% Internal Carotid Artery Stenosis in 288 Patients: Risk Factors for Disease Progression and Ipsilateral Neurological Symptoms
Anahita Dua, Bhavin Patel, Patrick Pindiur, Gary Seabrook, Peter Rossi
Medical College of Wisconsin, Milwaukee, WI.

 

3:50 pm
PS42. The Value of Near Infrared Spectroscopy and Transcranial Doppler to Predict the Onset of Cerebral Hyperperfusion Syndrome After Carotid Endarterectomy
Claire W. Pennekamp, Hester den Ruijter, Rogier Immink, L. Kappelle, Frans L. Moll, Wolfgang Buhre, Cyrille Ferrier, Gert-Jan de Borst
Vascular Surgery, UMCU, Utrecht, The Netherlands.

 

3:55 pm
PS44. Selective External Endarterectomy in Patients with Symptomatic Internal Carotid Artery Occlusion
Margriet Fokkema, Boudewijn Reichmann, Anne G. den Hartog, Catharina J. Klijn, Frans L. Moll, Gert-Jan de Borst
University Medical Center Utrecht, Utrecht, The Netherlands.

 

4:00 pm
PS46. A 20-year Experience with Surgical Management of True and False Internal Carotid Artery Aneurysms
Raffaele Pulli¹, Walter Dorigo¹, Alessandro Alessi Innocenti¹, Giovanni Pratesi², Aaron Fargion¹, Carlo Pratesi^1
1Vascular Surgery, University of Florence, Florence, Italy; ²University of Rome Tor Vergata, Rome, Italy.

 

4:05 pm
PS48. Impact of Patient’s Age on the Development of New Diffusion-weighted-positive Lesion on MRI After Carotid Endarterectomy and Carotid Artery Stenting
Yang Jin Park¹, Young-Wook Kim¹, Shin Suk Yang¹, Keun Myung Park¹, Dong-Ik Kim¹, Geon-Ha Kim², Pyeong Jeon², Kyong-Moon Kim³, Gwang-Woo Lee^3
1Division of Vascular Surgery, Samsung Medical Center, Seoul, Republic of Korea; ²Department of Radiology, Samsung Medical Center, Seoul, Republic of Korea; ³Department of Neurology, Samsung Medical Center, Seoul, Republic of Korea.

 

4:10 pm
PS50. Hemodynamic Instability Following Carotid Angioplasty and Stenting: Incidence, Predictors and Outcomes
Brant W. Ullery, Derek P. Nathan, Erin H. Murphy, Grace J. Wang, Benjamin M. Jackson, Benjamin J. Herdrich, Ronald M. Fairman, Edward Y. Woo
Surgery, University of Pennsylvania, Philadelphia, PA.

 

4:15 pm
PS52. What Makes a Carotid Plaque Really Symptomatic: The Difference is in the Surface
Laura Capoccia, Francesco Speziale, Enrico Sbarigia, Ivano P. Renzi, Andrea Esposito, Paolo Fiorani
Department of Surgery "P.Stefanini," Vascular Surgery Division, Policlinico Umberto I, University "La Sapienza," Rome, Italy.

 

4:20 pm
PS54. Risk-scoring System to Predict Three-year Survival in Patients Treated for Asymptomatic Carotid Stenosis
Francisco Alcocer, Marjan Mujib, Jeffrey Horn, Marc A. Passman, Mark A. Patterson, Thomas C. Matthews, William D. Jordan
Surgery, University of Alabama at Birmingham, Birmingham, AL.

3:40 pm
PS56. Impact of Distal Protection Filter Design in 30-day Outcomes of Carotid Artery Stenting
Natasha Loghmanpour¹, Gail Siewiorek¹, Kelly Wanamaker², Mark Wholey³, Rabih Chaer³, Satish Muluk², Ender A. Finol^4
1Carnegie Mellon University, Pittsburgh, PA; ²West Penn Allegheny Health System, Pittsburgh, PA; ³The University of Pittsburgh Medical Center, Pittsburgh, PA; ⁴The University of Texas at San Antonio, San Antonio, TX.

 

3:45 pm
PS58. Gender Differences in Presentation of Patients Undergoing CEA and CAS in VSGNE
Rodney P. Bensley, Ruby C. Lo, Rob Hurks, Elliot L. Chaikof, Allen D. Hamdan, Mark C. Wyers, Marc L. Schermerhorn
Surgery, Beth Israel Deaconess Medical Center, Boston, MA.

 

3:50 pm
PS60. Predictive Multivariate Regression to Increase the Specificity of Carotid Duplex for High-grade Stenosis
Jonathan J. Stone, Adam J. Doyle, Anthony Carnicelli, Sean J. Hislop, Michael Singh, Jason Kim, Jennifer L. Ellis, Nicholas J. Gargiulo, David L. Gillespie, Ankur Chandra
University of Rochester, Rochester, NY.

 

3:55 pm
PS62. Cross-sectional Area for the Calculation of Carotid Artery Stenosis on CT Angiography
Jonathan J. Stone, Adam J. Doyle, Anthony Carnicelli, Sean J. Hislop, Michael Singh, Jason Kim, Jennifer L. Ellis, Nicholas J. Gargiulo, David L. Gillespie, Ankur Chandra
University of Rochester, Rochester, NY.

 

4:00 pm
PS64. A Comparison of Carotid Endarterectomy and Carotid Artery Stenting in Patients Undergoing Cardiac Surgery
Paul J. Foley¹, Grace J. Wang¹, Edward Y. Woo¹, Jeffrey P. Carpenter², Michael A. Acker¹, Joseph Woo¹, Ronald M. Fairman¹, Benjamin M. Jackson^1
1Surgery, University of Pennsylvania, Philadelphia, PA; ²Robert Wood Johnson Medical School, Camden, NJ.

 

4:05 pm
PS66. Carotid Artery Segmentation and Wall Thickness Measurement Using CTA
Eric K. Shang, Alison M. Pouch, Chun Xu, Melissa M. Levack, Robert C. Gorman, Clyde F. Barker, Chandra M. Sehgal, Benjamin M. Jackson
Surgery, University of Pennsylvania, Philadelphia, PA.

 

4:10 pm
PS68. Association Between Carotid Artery Occlusion and Ultrasonographic Plaque Type: A Case Control Study
Constantine N. Antonopoulos, Triantafillos G. Giannakopoulos, Ioannis Vassilopoulos, George Sfyroeras, Konstantinos G. Moulakakis, John D. Kakisis, Christos D. Liapis
Athens University Medical School, Attikon University Hospital, Haidari, Greece.

 

4:15 pm
PS70. Alcohol Use Patterns as an Independent Risk Factor for Symptoms in Patients with Carotid Artery Stenosis
Sean J. Hislop, David L. Gillespie, Adam J. Doyle, Neil G. Kumar, Elisa Roztocil, John P. Cullen
University of Rochester, Division of Vascular Surgery, Rochester, NY.

 

4:20 pm
PS72. What is an Acceptable Morbidity Rate After Carotid Endarterectomy?
Elias Kfoury, Dipankar Mukherjee
Inova Fairfax Hospital, Falls Church, VA.

3:40 pm
PS74. Race, TAA and Disparities in Surgical Care: How TEVAR "Leveled the Playing Field"
Philip P. Goodney¹, Benjamin S. Brooke¹, Jessica B. Wallaert¹, Lori L. Travis³, Frances L. Lucas³, David A. Goodman², Jack L. Cronenwett¹, David H. Stone^1
1Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; ²The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH; ³Center for Outcomes Research and Evaluation (CORE), Portland, ME.

 

3:45 pm
PS76. Surgical Management of Vascular Access-related Complications in Hemodialysis Patients
Aneesh Srivastava, Manas R. Pradhan, Jatinder Kumar, M. S. Ansari, Rakesh Kapoor, S. K. Agrawal
Urology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

 

3:50 pm
PS78. Prevention of Vascular Access Hand Ischemia Using the Axillary Artery as Inflow
Robert E. Brown, William C. Jennings, John Blebea, Kevin Taubman, Ryan Messiner
Surgery, University of Oklahoma College of Medicine, Tulsa, OK.

 

3:55 pm
PS80. Significant Mechanical Puncture Resealing Properties of a Novel (Nano-composite) Compliant Hemodialyses Access Graft Compared to ePTFE Conduit Currently in Clinical Use
Debra S. Chong, Ramesh Batra, Ben Lindsey, Alex M. Seifalian, George Hamilton
Department of Surgery and Interventional Science, Royal Free Hospital, London, UK, London, United Kingdom.

 

4:00 pm
PS82. Graduating Vascular Surgery Trainees Have Low Self-reported Operative Confidence for Index Procedures
Cassidy Duran¹, Jean Bismuth¹, Erica L. Mitchell^2
1The Methodist DeBakey Heart & Vascular Center, Houston, TX; ²Oregon Health & Science University, Portland, OR.

 

4:05 pm
PS84. Mentorship and Medical Student Pre-clinical Exposure to Vascular Disease Will Improve Recruitment to a Vascular Surgery Career
Phong T. Dargon¹, Angela A. Kokkosis², Rabih A. Chaer³, Erica L. Mitchell^1
1Oregon Health & Science University, Portland, OR; ²The Mount Sinai Medical Center, New York City, NY; ³University of Pittsburgh, Pittsburgh, PA.

 

4:10 pm
PS86. Development and Validation of a Tool to Assess Performance of Simulated Open Abdominal Aortic Aneurysm Repair
William P. Robinson², Odette Taha², Donald T. Baril², Andres Schanzer², Jean Bismuth³, Erica L. Mitchell^1
1Vascular Surgery, Oregon Health & Science University, Portland, OR; ²UMass Memorial Medical Center, Worcester, MA; ³Methodist Cardiovascular Surgery Associates, Houston, TX.

 

4:15 pm
PS88. Repetition Using a High-fidelity Endovascular Simulator Improves Technical Performance with a High Retention Rate
Enrico Danzer², Natalia Martinez², Josef Luba², Melissa L. Kirkwood³, Benjamin M. Jackson1, Edward Y. Woo¹, Ronald M. Fairman¹, Grace J. Wang^1
1Vascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA; ²Hospital of the University of Pennsylvania, Philadelphia, PA; ³UT Southwestern Medical Center, Dallas, TX.

 

4:20 pm
PS90. No Significant Differences in Quality of Life Scores in Postoperative Neurogenic Patients Associated with Longer Follow-up
Danielle H. Rochlin, Marta M. Gilson, Kendall Likes, Emma Graf, Nancy Ford, Paul J. Christo, Julie A. Freischlag
Johns Hopkins Medical Institutions, Baltimore, MD.

3:40 pm
PS92. Popliteal Artery Aneurysm Eligibility for Endovascular Repair
James R. Ballard, Gregory J. Landry
Vascular Surgery, Oregon Health & Science University, Portland, OR.

 

3:45 pm
PS94. Do Women Have Worse Amputation-free Survival than Men Following Endovascular Procedures for Peripheral Arterial Disease? An Evaluation of the California State-wide Database
Nasim Hedayati, Ann Brunson, Chin-Shang Li, Aaron C. Baker, William C. Pevec, Patrick S. Romano
Surgery, University of California, Davis, Sacramento, CA.

 

3:50 pm
PS96. Routine Compared to Selective Use of Completion Imaging After Infrainguinal Lower Extremity Bypass is Not Associated with Higher Bypass Graft Patency
Tze-Woei Tan¹, Jeffrey Kalish¹, Naomi M. Hamburg¹, Andres Schanzer², Robert Eberhardt¹, Denis Rybin¹, Gheorghe Doros¹, Jack L. Cronenwett³, Alik Farber¹, For the Vascular Surgery Group of New England
¹Boston Medical Center/Boston University School of Medicine and Public Health, Boston, MA; ²UMass Memorial Medical Center, Boston, MA; ³Dartmouth-Hitchcock Medical Center, Lebanon, NH.

 

3:55 pm
PS98. Risk Factors for Premenopausal PAD: A Review of Manitoba Vascular Laboratory Databases from 1993-2010
April J. Boyd
Vascular Surgery, Health Sciences Centre, Winnipeg, MB, Canada.

 

4:00 pm
PS100. Prosthetic Graft vs. Vein as Conduit for Extra-anatomic Bypass: Short-term Outcomes from a National Database
Bala Natarajan¹, Prateek K. Gupta¹, Thomas G. Lynch⁴, Jason Mactaggart⁴, Marcus Balters¹, Himani Gupta², Xiang Fang³, G. Matthew Longo⁴, Jason M. Johanning⁴, Iraklis I. Pipinos^4
1Surgery, Creighton University, Omaha, NE; ²VA Nebraska and Western Iowa Health Care System, Omaha, NE; ³Creighton University-Department of Biostatistics, Omaha, NE; ⁴Departments of Surgery, University of Nebraska Medical Center, and VA Nebraska and Western Iowa Health Care System, Omaha, NE.

 

4:05 pm
PS102. Comparison Between Autologous Saphenous Vein and Heparin-bonded ePTFE Graft in the Treatment of Critical Limb Ischemia: A Trans-Atlantic Experience
Walter Dorigo¹, Raffaele Pulli¹, Patrizio Castelli², Vittorio Dorrucci³, Fiore Ferilli⁴, Giovanni De Blasis⁵, Vincenzo Monaca⁶, Enrico Vecchiati⁷, Richard Neville⁸, Carlo Pratesi^1
1Vascular Surgery, University of Florence, Florence, Italy; ²University of Insubria, Varese, Italy; 3Umberto I Hospital, Venice-Mestre, Italy; ⁴Santa Maria Hospital, Terni, Italy; ⁵SS. Filippo e Nicola Hospital, Avezzano, Italy; ⁶V.E. Ferrarotto S. Bambino Hospital, Catania, Italy; ⁷S. Maria Nuova Hospital, Reggio Emilia, Italy; ⁸George Washington University, Washington DC.

 

4:10 pm
PS104. Hypertensive Extracorporeal Limb Perfusion (HELP)
Martijn L. Dijkstra³, Rodney J. Lane¹, Walid Mohabbat^2
1Vascular Surgery, Royal North Shore Hospital, Sydney, NSW, Australia; ²Macquarie University Private Hospital, Sydney, NSW, Australia; ³Dalcross Private Hospital, Sydney, NSW, Australia.

 

4:15 pm
PS106. The Society for Vascular Surgery’s Objective Performance Goals: A Validation Study of Laser-assisted Angioplasty, A Safe and Effective Technique for the Management of Critical Limb Ischemia
Jonathan A. Higgins, Joanne J. Kim, Samuel N. Steerman, Sadaf S. Ahanchi, Babatunde Almaroof, Jean M. Panneton
Vascular Surgery, Eastern Virginia Medical School, Norfolk, VA.

 

4:20 pm
PS108. Impact of Intra-operative Local Vancomycin on Inguinal Wound Complications
George T. Pisimisis, Somala Mohammed, Shiva P. Daram, Carlos Bechara, Neal R. Barshes, Peter Lin, Panos Kougias
Baylor College of Medicine, Division of Vascular Surgery and Endovascular Therapy, Houston, TX.

3:40 pm
PS110. Anesthesia Type and Outcomes Following Lower Extremity Amputations
Michael R. Buckley¹, Thomas D. Conlee¹, Jeanette Andrews³, Christopher J. Godshall¹, Justin B. Hurie¹, Randolph L. Geary¹, Kimberley J. Hansen¹, Noel Harrington², Matthew S. Edwards^1
1Wake Forest Medical Center Department of Vascular and Endovascular Surgery, Winston-Salem, NC; ²Wake Forest Medical Center Department of Anesthesiology, Winston-Salem, NC; ³Wake Forest Medical School Department of Biostatistical Sciences, Winston-Salem, NC.

 

3:45 pm
PS112. A Femorofemoral Bypass for Aneurysmal or Stenotic Arterial Disease: Is There a Difference in Outcome?
Herman J. Zandvoort¹, Ellen D. Kaan¹, Jean-Paul P. de Vries², Frans L. Moll¹, Joost A. van Herwaarden^1
1University Medical Center Utrecht, Utrecht, The Netherlands; ²St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.

 

3:50 pm
PS114. The Retrogeniculate Popliteal Artery is Valid Territory for Stenting
Rishi Kundi, Nii-Kabu Kabutey, Francesco Aiello, Andrew J. Meltzer, John Karwowski, Peter H. Connolly
New York-Presbyterian Hospital/Weill Cornell Medical College, New York, NY.

 

3:55 pm
PS116. Major Limb Amputation is Higher in Regions with Limited Access to Cardiovascular Specialists
Katharine L. McGinigle¹, Peter J. Leese³, Thomas C. Ricketts², William A. Marston^1
1Department of Surgery, University of North Carolina, Chapel Hill, NC; ²Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC; ³Department of Performance Improvement and Patient Safety, University of North Carolina Healthcare, Chapel Hill, NC.

 

4:00 pm
PS118. Extent of COPD is Associated with Short- and Long-term Adverse Outcomes in Patients Undergoing Elective AAA Repair
David H. Stone¹, Philip P. Goodney¹, Andres Schanzer², Jeffrey Kalish³, Jeffrey Indes⁴, Randall R. De Martino¹, Daniel B. Walsh¹, Jack L. Cronenwett¹, Brian W. Nolan^1
1Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; ²University of Massachusetts Medical School, Worcester, MA; ³Boston Medical Center, Boston, MA; 4Yale School of Medicine, New Haven, CT.

 

4:05 pm
PS120. Regional Primary Care Utilization Impacts Readmissions After Complex Vascular Surgery
Benjamin S. Brooke¹, David H. Stone¹, Jack L. Cronenwett¹, Randall R. De Martino¹, Andrew W. Hoel¹, Richard J. Powell¹, Lori L. Travis³, David C. Goodman², Philip P. Goodney^1
1Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; ²Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH; ³Maine Medical Center, Portland, ME.

 

4:10 pm
PS122. Negative Pressure Wound Therapy on Exposed Prosthetic Vascular Grafts in the Groin
Paul Berger, Dennis de Bie, Frans L. Moll, Gert-Jan de Borst
UMC Utrecht, Utrecht, The Netherlands.

 

4:15 pm
PS124. Experience with a New Negative Pressure Incision Management System in Prevention of Groin Wound Infection in Vascular Surgery Patients
Tim Matatov, Kaavya Reddy, Linda M. Doucet, Wayne W. Zhang
Division of Vascular and Endovascular Surgery, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA.

 

4:20 pm
PS126. Influence of Obesity on Groin Surgical Site Infections After Vascular Surgery
Laura Peterson, Jean Starr
The Ohio State University Medical Center, Columbus, OH.

3:40 pm
PS128. In-hospital and Post-discharge Venous Thromboembolism After Vascular Surgery
Bala Natarajan¹, Prateek K. Gupta¹, Thomas G. Lynch², Jason Mactaggart³, Marcus Balters¹, Himani Gupta², G. Matthew Longo³, Jason M. Johanning³, Iraklis I. Pipinos^3
1Surgery, Creighton University, Omaha, NE; ²VA Nebraska and Western Iowa Health Care System, Omaha, NE; ³Departments of Surgery, University of Nebraska Medical Center, and VA Nebraska and Western Iowa Health Care System, Omaha, NE.

 

3:45 pm
PS130. Factors Impacting Follow-up Care After Placement of Temporary Inferior Vena Cava Filters
Elsie Gyang, Mohamed Zayed, E. John Harris, Jason T. Lee, Ronald L. Dalman, Matthew W. Mell
Vascular Surgery, Stanford University Hospital & Clinics, Stanford, CA.

 

3:50 pm
PS132. Functional Outcomes Following Catheter-based Iliac Vein Stent Placement
Courtney J. Warner, Daniel B. Walsh, Philip P. Goodney, Brian W. Nolan, Eva M. Rzucidlo, Andrew W. Hoel, Richard J. Powell, David H. Stone
Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

 

3:55 pm
PS134. Endovenous Valve Transfer for Chronic Venous Hypertension
Martijn L. Dijkstra², Walid Mohabbat³, Rodney J. Lane¹, Michael Cuzzilla^2
1Vascular Surgery, Royal North Shore Hospital, Sydney, NSW, Australia; ²Dalcross Private Hospital, Sydney, NSW, Australia; ³Macquarie University Private Hospital, Sydney, NSW, Australia.

 

4:00 pm
PS136. Effect of Pregnancy on Exostent Venous Valve Repair at the Sapheno Femoral Junction (SFJ)
Martijn L. Dijkstra², Rodney J. Lane¹, Walid Mohabbat^3
1Vascular Surgery, Royal North Shore Hospital, Sydney, NSW, Australia; ²Dalcross Private Hospital, Sydney, NSW, Australia; ³Macquarie University Private Hospital, Sydney, NSW, Australia.

 

4:05 pm
PS138. Capturing the Visual Impact of Varicose Veins
John Kingsley¹, Thomas King², Elizabeth Orfe², David Wright^2
1Alabama Vascular and Vein Center, Vestavia Hills, AL; ²BTG International Inc., West Conshohocken, PA.

 

4:10 pm
PS140. Secondary Vena Cava Filter Insertion During Surgical Procedures: Characterization and Comparison with Rates of Perioperative Venous Thromboembolism
Yazan Duwayri¹, Robert C. Allen², Jennifer Avise², Luke P. Brewster², Ravi R. Rajani², Ravi K. Veeraswamy², Matthew S. Edwards³, Philip P. Goodney⁴, Matthew A. Corriere^1
1Emory University School of Medicine/Atlanta VA Medical Center, Atlanta, GA; ²Emory University School of Medicine, Atlanta, GA; ³Wake Forest School of Medicine, Winston-Salem, NC; ⁴Dartmouth-Hitchcock Medical Center, Lebanon, NH.

 

4:15 pm
PS142. Rates of Elastic Compression Stockings Prescription Following Diagnosis of Deep Venous Thrombosis
Ahmed Kayssi, Andrew Petrosoniak, Jeremy Levenstadt, Naomi Eisenberg, Graham Roche-Nagle
Department of Vascular Surgery, Toronto General Hospital, Toronto, ON, Canada.

 

4:20 pm
PS144. Rare Incidence of Pulmonary Embolism Following Upper Extremity DVT (UEDVT) Suggests Role for More Selective Anticoagulation
Mark M. Levy, Francisco C. Albuquerque, Michael F. Amendola, Derek R. Brinster, John Pfeifer
Surgery, Virginia Commonwealth University, Richmond, VA.

3:40 pm
PS146. Upper-body Exercise Increases Lower-extremity Venous Blood Flow
Kevin J. Caldwell¹, Steven J. Prior², Meghan Kampmann¹, Limin Zhao¹, Sue McEvoy¹, Brajesh K. Lal^1
1University of Maryland School of Medicine, Baltimore, MD; ²Baltimore Veterans Affairs Geriatric Research, Education and Clinical Center, Baltimore, MD.

 

3:45 pm
PS148. Varicose Veins (VV) Symptoms Questionnaire: A Simple, Validated Measure of VV Symptoms that Can Be Administered Daily Using a Personal Digital Assistant (PDA)
Andrew Bradbury¹, Gareth Bate¹, Emma Thomas², Thomas King², David Wright^2
1College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; ²BTG International Inc., West Conshohocken, PA.

 

3:50 pm
PS150. Saphenous Vein Recanalization After Radiofrequency Ablation: Incidence and Associated Risk Factors
Jack L. Eidson¹, Deepa Raghunathan¹, Marvin D. Atkins¹, Clifford J. Buckley¹, Ruth L. Bush², William T. Bohannon^1
1Vascular Surgery, Scott and White, Temple, TX; ²Central Texas VA Hospital, Temple, TX.

 

3:55 pm
PS152. Calf Deep Vein Thrombosis: Current Trends in Management
Arjun Jayaraj, Brenda Zierler, Mark Meissner
University of Washington, Seattle, WA.

 

4:00 pm
PS154. Trends in Outpatient Treatment of Vascular Diseases
Michael Yen¹, Natalia N. Egorova¹, Alan J. Moskowitz¹, Eugene A. Sosunov², James F. McKinsey², Roman Nowygrod^2
1Mount Sinai School of Medicine, New York, NY; ²Columbia University, New York Presbyterian Hospital, New York, NY.

 

4:05 pm
PS156. Surgical Management of Infected Femoral Artery Pseudoaneurysms: A Contemporary Series
Sherene Shalhub, Benjamin W. Starnes, Brandon T. Garland, Anthony J. Pirot, Nam T. Tran
Vascular Surgery Division, University of Washington, Seattle, WA.

 

4:10 pm
PS158. Blunt Aortic Injury Does Not Warrant Emergent Repair
Ahsan T. Ali, Mark Wright, J. Greg Modrall, Mohammad Moursi, John F. Eidt
Surgery, University of Arkansas for Medical Sciences, Little Rock, AR.

 

4:15 pm
PS160. Treatment of Blunt Traumatic Aortoiliac Injury: A Single Institution Experience
Kristofer M. Charlton-Ouw¹, Miguel Sanchez-Perez¹, Samuel S. Leake¹, David Hamilton², John B. Holcomb², Rosemary A. Kozar², Ali Azizzadeh¹, Anthony L. Estrera¹, Hazim J. Safi^1
1Department of Cardiothoracic and Vascular Surgery, University of Texas Medical School at Houston, Houston, TX; ²Department of Surgery, University of Texas Medical School at Houston, Houston, TX.

 

4:20 pm
PS162. Racial Differences in Treatment and Mortality Following Vascular Injury: A National Trauma Data Bank Analysis
Charles Briggs, Tze-Woei Tan, Denis Rybin, Gheorghe Doros, Robert Eberhardt, Naomi M. Hamburg, Alik Farber
Boston Medical Center, Boston, MA.

3:40 pm
PS164. Estimating the Risk of Leukemia in Patients Undergoing Routine CT Scans for Postoperative Surveillance After Endovascular Aneurysm Repair (POS-EVAR)
Raghu L. Motaganahalli, Angela Martin, James Slaven, Gary W. Lemmon, Alok Gupta, Alan P. Sawchuk, Andres Fajardo, George Akingba, Dolores Cikrit, Michael Murphy, Michael C. Dalsing
Surgery-Section of Vascular Surgery, Indiana University School of Medicine, Indianapolis, IN.

 

3:45 pm
PS166. Risk Factors for Prevalence and Progression of Asymptomatic Carotid Disease in Patients with Peripheral Arterial Disease
Francesco A. Aiello, Andrew J. Meltzer, Brian Cohen, Melinda Espiritu, Jason Burmeister, Rahima Hoque, James F. McKinsey, Gautum Shrikhande
Vascular Surgery, New York Presbyterian Hospital, New York, NY.

 

3:50 pm
PS168. Novel Aorto-Ilio-Femoral Assessment (AIFA) for the Evaluation of Access Vessels Based on Unenhanced Computer Tomography
Jane K. Yang, Alan Heldman, Handel Robinson, Jorge Rey, Arash Bornak, William O' Neill, Omaida Velazquez
University of Miami Hospital, Miami, FL.

 

3:55 pm
PS170. A Cross-sectional Analysis of Femoral Artery Intima-media Thickness
Grace J. Wang, Andrew J. Layne, Emile R. Mohler, Julia T. Davis, Seema S. Sonnad, Ronald M. Fairman
Vascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.

 

4:00 pm
PS172. Accuracy of Sharp Monophasic Waveform in Predicting Distal Arterial Disease in Lower Extremity
Neelima Katragunta, Joel Clements, Josh Lee, Christopher LeSar, Larry R. Sprouse
University of Tennessee, Chattanooga, TN.

 

4:05 pm
PS174. Technical Superiority and Clinical Excellence of Duplex Ultrasound Arterial Mapping (DUAM) vs. Magnetic Resonance Angiogram (MRA), as the Sole Imaging Modality in Bypass Surgery (BS) and Endovascular Revascularization (EVR) for Critical Lower Ischemia (CLI) Patients. Six Years Comparative Study in a Tertiary Referral Vascular Center
Sherif Sultan², Wael Tawfick^1
1Vascular & Endovascular Surgery, Western Vascular Institute, Galway, Ireland; ²Galway Clinic, Galway, Ireland.

 

4:10 pm
PS176. CT Angiography-based Cross-sectional Area Measurements for Carotid Stenosis with Contralateral Carotid Occlusion
Anthony Carnicelli, Jonathan Stone, Adam J. Doyle, David Gillespie, Michael Singh, Jason Kim, Baback Jahromi, Ankur Chandra
University of Rochester Medical Center, Rochester, NY.

 

4:15 pm
PS178. Non-operative Treatment of Spontaneous Visceral Artery Dissection
Eileen de Grandis, Adam Power, Manju Kalra, Robert McBane, Christine Lohse, Thomas C. Bower
Mayo Clinic, Rochester, MN.

 

4:20 pm
PS180. Nonoperative Management of Isolated Spontaneous Dissection of the Renal Artery
Adam H. Power, Thomas C. Bower, Manju Kalra, Audra A. Duncan, Gustavo S. Oderich, Robert McBane, Eddie Greene, Peter Gloviczki
Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.

3:40 pm
PS182. Skeletal Muscle Damage in Critical Limb Ischemia (CLI) is Mediated via the MyD88-dependent Signalling Pathway
Hemanshu Patel¹, George Hamilton¹, David Abraham¹, Daryll Baker¹, Sidney Shaw², Janice Tsui^1
1Division of Surgery & Interventional Science, UCL, London, United Kingdom; ²University of Bern, Bern, Switzerland.

 

3:45 pm
PS184. Lung Endothelial Cell Apoptosis During Ischemic Acute Kidney Injury
Laura E. White¹, Yan Cui¹, Carolyn M. Feltes Shelak³, Heitham T. Hassoun^2
1The Methodist Hospital and Research Institute, Houston, TX; ²The Methodist Hospital and Research Institute and The Methodist DeBakey Heart & Vascular Center, Houston, TX; ³The Johns Hopkins School of Medicine, Baltimore, MD.

 

3:50 pm
PS186. Adipose-derived Stem Cells from Diabetic Patients as Endothelial Cell Substitutes in Vascular Tissue Engineering
Aleksandra Policha¹, Ping Zhang¹, Bing Shue², Amanda Smolock², Lily Chang², Masaya Jimbo², Thomas Tulenko³, Neil Moudgill⁴, Anumeha Whisenhunt⁴, Atul Rao⁴, Joshua Eisenberg⁴, Paul DiMuzio^4
1Thomas Jefferson University Hospital, Department of General Surgery, Philadelphia, PA; ²Jefferson Medical College, Philadelphia, PA; ³Cooper University Hospital, Camden, NJ; ⁴Thomas Jefferson University Hospital, Department of General Surgery, Division of Vascular and Endovascular Surgery, Philadelphia, PA.

 

3:55 pm
PS188. Prevention of Intimal Hyperplasia: The Role of Short-term Oxygen AdministrationDerrick L. Green¹, Charu Lata², Jing Wan¹, Sabita Roy¹, Steven M. Santilli^1
1Department of Surgery, University of Minnesota, Minneapolis, MN; ²Veterans Affairs Medical Center, Minneapolis, MN.

 

4:00 pm
PS190. Ischemia Mediates Myogenic Progenitor Cell Dysfunction
Matthew Fincher, David Abraham, George Hamilton, Daryll Baker, Janice Tsui
Royal Free Hospital, London, United Kingdom.

 

4:05 pm
PS192. The Pro-proliferative and Anti-apoptotic Micro-RNA 221 is Decreased in Vulnerable Carotid Atherosclerotic Plaques
Hernan A. Bazan, Chasity B. Coleman, Taylor Smith, W. Charles Sternbergh III, T. Cooper Woods
Ochsner Clinic, New Orleans, LA.

 

4:10 pm
PS194. Role of PI3k/Akt Pathway in the Cytoprotective Effects of Erythropoietin and Derivatives in Ischemic Human Myotubes
Rebekah Yu, George Hamilton, Daryll Baker, Janice Tsui
Department of Surgery, University College London, London, United Kingdom.

 

4:15 pm
PS196. Tracking the Migration of Porcine Mesenchymal Stem Cells with the MRI Contrast Agent Ferex in an AAA Model
Rami Tadros, Bhakti Rawal, Karen Briley-Saebo, David O'Connor, Dan Han, Roger Hajjar, Zahi Fayad, Michael Marin, Peter Faries
The Mount Sinai School of Medicine, New York, NY.

 

4:20 pm
PS198. Vascular Endothelial Growth Factor-C Derived from CD11b Positive Macrophages Induces Therapeutic Improvements in a Murine Model of Hind Limb Ischemia
Go Kuwahara¹, Hitomi Nishinakamura², Tadashi Tashiro¹, Shohta Kodama^2
1Department of Cardiovascular Surgery, Faculty of Medicine, Fukuoka University, Fukuoka City, Japan; ²Department of Regenerative Medicine & Transplantation, Faculty of Medicine, Fukuoka University, Fukuoka City, Japan.

3:40 pm
PS200. Performance of a Nanocomposite Polymer Small Diameter Bypass Graft in a Long-term Sheep Model
Mital Desai¹, Maqsood Ahmed², Achala de Mel², Janice Tsui¹, Alexander M. Seifalian², George Hamilton^1
1Royal Free Hampstead NHS Trust, London, United Kingdom; ²University College London, London, United Kingdom.

 

3:45 pm
PS202. Biomarkers for Subclinical Renal Injury Following Endovascular Aneurysm Repair in Human Subjects
Katie E. Rollins¹, Ayesha Noorani¹, Keith Burling², Jonathan Boyke^1
1Department of Vascular Surgery, Addenbrookes Hospital, Cambridge, United Kingdom; ²Addenbrookes Hospital ̶ Department of Chemical Pathology, Cambridge, United Kingdom.

 

3:50 pm
PS204. Mechanical (or “Gravitational”) Unloading Reduces Inflammatory and Cell Adhesion Molecule Gene Expression in Human Endothelial Cells
Marlene Grenon, Jesus Aguado-Zunega, Michael S. Conte, Millie Hughes-Fulford
UCSF, San Francisco, CA.

 

3:55 pm
PS206. Wall Thickness Influence on Computational Wall Stress of Arteries
Eric K. Shang¹, Chun Xu¹, Derek P. Nathan¹, Ronald M. Fairman¹, Robert C. Gorman¹, Joseph H. Gorman¹, Sarah C. Vigmostad², Benjamin M. Jackson^1
1Surgery, University of Pennsylvania, Philadelphia, PA; ²University of Iowa, Iowa City, IA.

 

4:00 pm
PS208. Edaravone Injected at the Start of Reperfusion Reduces Muscle Injury Following Leg Ischemia in Rats
Mitsuhiro Yamamaura, Yuji Miyamoto, Masataka Mitsuno, Hiroe Tanaka, Masaaki Ryomoto, Shinya Fukui, Yoshiteru Yoshioka
Department of Cardiovascular Surgery, Hyogo College of Medicine, Nishinomiya, Japan.

 

4:05 pm
PS210. The Potential for Ascorbic Acid Mediated Nephroprotection in an Animal Model of Contrast-induced Nephropathy Following Endovascular Aneurysm Repair
Katie E. Rollins¹, Ayesha Noorani¹, Lucie Janeckova², Meryl Griffiths³, Matthew Baker², Jonathan Boyle^1
1Department of Vascular Surgery, Addenbrookes Hospital, Cambridge, United Kingdom; ²Antitope Ltd., Babraham Research Campus, United Kingdom; ³Addenbrookes Hospital ̶ Department of Histopathology, Cambridge, United Kingdom.

 

4:10 pm
PS212. Evaluation of Porcine Dermal Collagen (Permacol) as an Alternative Vascular Conduit for Interposition Grafting in the Presence of Bacterial Contamination in a Rabbit Model
Todd E. Simon¹, Anna L. Naig¹, Joel R. Brockmeyer¹, Robert D. Rice¹, Balakrishna M. Prasad², Paul W. White^1
1Peripheral Vascular Surgery Service, Dwight David Eisenhower Army Medical Center, Fort Gordon, GA; ²Department of Clinical Investigation, Dwight David Eisenhower Army Medical Center, Fort Gordon, GA.

 

4:15 pm
PS214. Aging Does Not Affect Muscle Regenerative Capacity in Mice
Heather M. Hancock¹, Mathew McHale¹, Laurel Porter¹, Zaheer Sarwar¹, Linda M. McManus¹, Paula K. Shireman^2
1General Surgery, UTHSCSA, San Antonio, TX; ²VA, San Antonio, TX.

 

4:20 pm
PS216. Angiogenesis Inhibitor Sunitinib Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysm
Yasunori Iida², Baohui Xu¹, Xiaolei Hu¹, Vinca Chow¹, Richard Yuan¹, Mary Gerritsen¹, Hitoshi Ogino², Ronald L. Dalman^1
1Stanford University School of Medicine, Stanford, CA; ²Tokyo Medical University, Tokyo, Japan.

 

4:55 pm
Announcement of Winning Posters in Each Respective Category
Room: Exhibit Halls A-C